Frederick G. Vogt - Interim CEO & General Counsel, Director at IOVANCE BIOTHERAPEUTICS, INC.

Issuer-level insider activity

Role: Interim CEO & General Counsel, Director
Issuer ticker: IOVA on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Frederick G. Vogt since 13 Sep 2025

Reported holdings for Frederick G. Vogt in IOVANCE BIOTHERAPEUTICS, INC.

Form 4 holding Interim CEO & General Counsel, Director

IOVANCE BIOTHERAPEUTICS, INC.

Security class: Common Stock
Shares / value: 595,447
Estimated value: $2,477,059
Report date: 08 Sep 2026
Price: $4.16
Ownership: Direct

Form 4 holding Interim CEO & General Counsel, Director

IOVANCE BIOTHERAPEUTICS, INC.

Security class: Restricted Stock Units
Shares / value: 93,756
Estimated value
Report date: 08 Sep 2026
Price
Ownership: Direct
Underlying class: Common stock
Underlying amount

Transaction history for Frederick G. Vogt in IOVANCE BIOTHERAPEUTICS, INC.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .